Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Mannelli

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 1, 2011
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation statusGraeme Eisenhofer, Jacques W M Lenders, Gabriele Siegert, et al.
International Journal of Endocrinology|June 23, 2020
Germline Mutation in <i>KIF1Bβ</i> Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with PheochromocytomaGiuseppina De Filpo, Elisa Contini, Viola Serio, et al.
World Journal of Surgical Oncology|June 27, 2023
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective studyGiuseppina De Filpo, Gabriele Parenti, Clotilde Sparano, et al.
The Journal of Clinical Endocrinology and Metabolism|April 25, 2014
Pitfalls in genetic analysis of pheochromocytomas/paragangliomas-case reportLetizia Canu, Elena Rapizzi, Benedetta Zampetti, et al.
Endocrine-Related Cancer|December 4, 2009
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse modelMichaela Luconi, Monica Mangoni, Stefania Gelmini, et al.
Endocrine Pathology|March 23, 2023
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical CarcinomaMichaela Luconi, Giulia Cantini, Rachel S van Leeuwaarde, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor locationGraeme Eisenhofer, Henri J Timmers, Jacques W M Lenders, et al.
Oncotarget|October 15, 2017
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancerFrancesca Salvianti, Letizia Canu, Giada Poli, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2018
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical CarcinomaGiada Poli, Carmen Ruggiero, Giulia Cantini, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Novel Germline <i>PHD2</i> Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of PolycythemiaAldesia Provenzano, Massimiliano Chetta, Giuseppina De Filpo, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|November 1, 2011
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation statusGraeme Eisenhofer, Jacques W M Lenders, Gabriele Siegert, et al.
International Journal of Endocrinology|June 23, 2020
Germline Mutation in <i>KIF1Bβ</i> Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with PheochromocytomaGiuseppina De Filpo, Elisa Contini, Viola Serio, et al.
World Journal of Surgical Oncology|June 27, 2023
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective studyGiuseppina De Filpo, Gabriele Parenti, Clotilde Sparano, et al.
The Journal of Clinical Endocrinology and Metabolism|April 25, 2014
Pitfalls in genetic analysis of pheochromocytomas/paragangliomas-case reportLetizia Canu, Elena Rapizzi, Benedetta Zampetti, et al.
Endocrine-Related Cancer|December 4, 2009
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse modelMichaela Luconi, Monica Mangoni, Stefania Gelmini, et al.
Endocrine Pathology|March 23, 2023
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical CarcinomaMichaela Luconi, Giulia Cantini, Rachel S van Leeuwaarde, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor locationGraeme Eisenhofer, Henri J Timmers, Jacques W M Lenders, et al.
Oncotarget|October 15, 2017
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancerFrancesca Salvianti, Letizia Canu, Giada Poli, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2018
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical CarcinomaGiada Poli, Carmen Ruggiero, Giulia Cantini, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Novel Germline <i>PHD2</i> Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of PolycythemiaAldesia Provenzano, Massimiliano Chetta, Giuseppina De Filpo, et al.
Pageof 14